Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 10
2004 5
2006 2
2007 1
2008 4
2009 4
2010 3
2011 6
2012 3
2013 3
2014 3
2015 5
2016 1
2017 2
2018 4
2019 3
2021 3
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
A call to arms: Unifying the fight against resistance.
Kaushansky A, Hedstrom L, Goldman A, Singh J, Yang PL, Rathod PK, Cynamon M, Wodarz D, Mahadevan D, Tomaras A, Navia MA, Schiffer CA. Kaushansky A, et al. Among authors: cynamon m. Sci Signal. 2018 Oct 23;11(553):eaav0442. doi: 10.1126/scisignal.aav0442. Sci Signal. 2018. PMID: 30352947 Free PMC article.
2-N-Arylthiazole inhibitors of Mycobacterium tuberculosis.
Clark MP, Wang T, Perola E, Deininger DD, Zuccola HJ, Jones SM, Gao H, VanderVen BC, Russell DG, Shoen CM, Cynamon MH, Thomson JA, Locher CP. Clark MP, et al. Among authors: cynamon mh. Bioorg Med Chem Lett. 2017 Sep 1;27(17):3987-3991. doi: 10.1016/j.bmcl.2017.07.067. Epub 2017 Jul 27. Bioorg Med Chem Lett. 2017. PMID: 28778468
Emerging drugs for the treatment of tuberculosis.
Yew WW, Cynamon M, Zhang Y. Yew WW, et al. Among authors: cynamon m. Expert Opin Emerg Drugs. 2011 Mar;16(1):1-21. doi: 10.1517/14728214.2011.521497. Epub 2010 Sep 26. Expert Opin Emerg Drugs. 2011. PMID: 20868293 Review.
Therapy for Mycobacterium kansasii Infection: Beyond 2018.
DeStefano MS, Shoen CM, Cynamon MH. DeStefano MS, et al. Among authors: cynamon mh. Front Microbiol. 2018 Sep 24;9:2271. doi: 10.3389/fmicb.2018.02271. eCollection 2018. Front Microbiol. 2018. PMID: 30319580 Free PMC article.
Development potential of rifalazil.
Rothstein DM, Hartman AD, Cynamon MH, Eisenstein BI. Rothstein DM, et al. Among authors: cynamon mh. Expert Opin Investig Drugs. 2003 Feb;12(2):255-71. doi: 10.1517/13543784.12.2.255. Expert Opin Investig Drugs. 2003. PMID: 12556219 Review.
Synthesis and Testing of Analogs of the Tuberculosis Drug Candidate SQ109 against Bacteria and Protozoa: Identification of Lead Compounds against Mycobacterium abscessus and Malaria Parasites.
Stampolaki M, Malwal SR, Alvarez-Cabrera N, Gao Z, Moniruzzaman M, Babii SO, Naziris N, Rey-Cibati A, Valladares-Delgado M, Turcu AL, Baek KH, Phan TN, Lee H, Alcaraz M, Watson S, van der Watt M, Coertzen D, Efstathiou N, Chountoulesi M, Shoen CM, Papanastasiou IP, Brea J, Cynamon MH, Birkholtz LM, Kremer L, No JH, Vázquez S, Benaim G, Demetzos C, Zgurskaya HI, Dick T, Oldfield E, Kolocouris AD. Stampolaki M, et al. Among authors: cynamon mh. ACS Infect Dis. 2023 Feb 10;9(2):342-364. doi: 10.1021/acsinfecdis.2c00537. Epub 2023 Jan 27. ACS Infect Dis. 2023. PMID: 36706233 Free PMC article.
Modeling the HIV-1 Antiretroviral Therapeutic Drug Interaction.
Damianopoulos EN, Cynamon M. Damianopoulos EN, et al. Among authors: cynamon m. AIDS Res Hum Retroviruses. 2018 Dec;34(12):1011-1012. doi: 10.1089/AID.2018.0113. AIDS Res Hum Retroviruses. 2018. PMID: 30073843 No abstract available.
58 results